6
|
Wang Y, Smith S, Teichtahl AJ, Hodge AM, Wluka AE, Giles GG, Cicuttini FM. Association Between Dietary Intake of Antioxidants and Prevalence of Femoral Head Cartilage Defects and Bone Marrow Lesions in Community-based Adults. J Rheumatol 2016; 43:1885-1890. [PMID: 27481903 DOI: 10.3899/jrheum.160325] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 06/30/2016] [Indexed: 11/22/2022]
Abstract
OBJECTIVE Although there is evidence for a beneficial effect of dietary antioxidants on knee joint health, the data are sparse for the hip. Our aim was to examine the relationship between dietary antioxidants and early hip structural abnormalities in community-based adults. METHODS The study included 214 participants without diagnosed hip osteoarthritis (OA) who underwent hip magnetic resonance imaging in 2009-2010. The prevalence of femoral head cartilage defects and bone marrow lesions (BML) was assessed. Intakes of antioxidant vitamins and their food sources were estimated from a food frequency questionnaire during 1990-1994. RESULTS Higher intakes of Vitamin E (OR 0.63, 95% CI 0.41-0.96), lutein/zeaxanthin (OR 0.58, 95% CI 0.34-0.99), and lycopene (OR 0.64, 95% CI 0.44-0.95) were associated with a reduced prevalence of femoral head cartilage defects. Higher intakes of α-carotene (OR 0.42, 95% CI 0.19-0.94), β-carotene (OR 0.31, 95% CI 0.13-0.78), and lutein/zeaxanthin (OR 0.42, 95% CI 0.18-0.98) were associated with a reduced prevalence of femoral head BML. Higher vegetable consumption was associated with a reduced prevalence of femoral head cartilage defects (OR 0.65, 95% CI 0.46-0.91) and BML (OR 0.60, 95% CI 0.37-0.97). CONCLUSION Higher carotenoids intake and vegetable consumption were associated with reduced risk of hip cartilage defects and BML, and higher Vitamin E intake was associated with reduced risk of hip cartilage defects. These findings suggest a beneficial effect of dietary antioxidants on hip joint health. Although our findings need to be confirmed in other longitudinal studies, they suggest that the modification of dietary antioxidant intake may be a strategy for the prevention of hip OA.
Collapse
Affiliation(s)
- Yuanyuan Wang
- From the Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Alfred Hospital, Melbourne; Baker IDI Heart and Diabetes Institute; Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Carlton, Australia.Y. Wang, MBBS, MD, PhD, Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Alfred Hospital; S. Smith, MBBS, Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Alfred Hospital; A.J. Teichtahl, MBBS, B.Physio, FRACP, PhD, Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Alfred Hospital, and Baker IDI Heart and Diabetes Institute; A.M. Hodge, BAgrSci, Grad Dip Diet, BSc, MEnvSc, Grad Dip Epi Biostats, Cancer Epidemiology Centre, Cancer Council Victoria; A.E. Wluka, MBBS, FRACP, PhD, Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Alfred Hospital; G.G. Giles, PhD, Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Alfred Hospital, and Cancer Epidemiology Centre, Cancer Council Victoria, and Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne; F.M. Cicuttini, MBBS, FRACP, PhD, Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Alfred Hospital.
| | - Sam Smith
- From the Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Alfred Hospital, Melbourne; Baker IDI Heart and Diabetes Institute; Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Carlton, Australia.Y. Wang, MBBS, MD, PhD, Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Alfred Hospital; S. Smith, MBBS, Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Alfred Hospital; A.J. Teichtahl, MBBS, B.Physio, FRACP, PhD, Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Alfred Hospital, and Baker IDI Heart and Diabetes Institute; A.M. Hodge, BAgrSci, Grad Dip Diet, BSc, MEnvSc, Grad Dip Epi Biostats, Cancer Epidemiology Centre, Cancer Council Victoria; A.E. Wluka, MBBS, FRACP, PhD, Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Alfred Hospital; G.G. Giles, PhD, Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Alfred Hospital, and Cancer Epidemiology Centre, Cancer Council Victoria, and Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne; F.M. Cicuttini, MBBS, FRACP, PhD, Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Alfred Hospital
| | - Andrew J Teichtahl
- From the Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Alfred Hospital, Melbourne; Baker IDI Heart and Diabetes Institute; Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Carlton, Australia.Y. Wang, MBBS, MD, PhD, Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Alfred Hospital; S. Smith, MBBS, Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Alfred Hospital; A.J. Teichtahl, MBBS, B.Physio, FRACP, PhD, Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Alfred Hospital, and Baker IDI Heart and Diabetes Institute; A.M. Hodge, BAgrSci, Grad Dip Diet, BSc, MEnvSc, Grad Dip Epi Biostats, Cancer Epidemiology Centre, Cancer Council Victoria; A.E. Wluka, MBBS, FRACP, PhD, Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Alfred Hospital; G.G. Giles, PhD, Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Alfred Hospital, and Cancer Epidemiology Centre, Cancer Council Victoria, and Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne; F.M. Cicuttini, MBBS, FRACP, PhD, Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Alfred Hospital
| | - Allison M Hodge
- From the Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Alfred Hospital, Melbourne; Baker IDI Heart and Diabetes Institute; Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Carlton, Australia.Y. Wang, MBBS, MD, PhD, Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Alfred Hospital; S. Smith, MBBS, Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Alfred Hospital; A.J. Teichtahl, MBBS, B.Physio, FRACP, PhD, Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Alfred Hospital, and Baker IDI Heart and Diabetes Institute; A.M. Hodge, BAgrSci, Grad Dip Diet, BSc, MEnvSc, Grad Dip Epi Biostats, Cancer Epidemiology Centre, Cancer Council Victoria; A.E. Wluka, MBBS, FRACP, PhD, Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Alfred Hospital; G.G. Giles, PhD, Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Alfred Hospital, and Cancer Epidemiology Centre, Cancer Council Victoria, and Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne; F.M. Cicuttini, MBBS, FRACP, PhD, Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Alfred Hospital
| | - Anita E Wluka
- From the Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Alfred Hospital, Melbourne; Baker IDI Heart and Diabetes Institute; Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Carlton, Australia.Y. Wang, MBBS, MD, PhD, Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Alfred Hospital; S. Smith, MBBS, Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Alfred Hospital; A.J. Teichtahl, MBBS, B.Physio, FRACP, PhD, Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Alfred Hospital, and Baker IDI Heart and Diabetes Institute; A.M. Hodge, BAgrSci, Grad Dip Diet, BSc, MEnvSc, Grad Dip Epi Biostats, Cancer Epidemiology Centre, Cancer Council Victoria; A.E. Wluka, MBBS, FRACP, PhD, Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Alfred Hospital; G.G. Giles, PhD, Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Alfred Hospital, and Cancer Epidemiology Centre, Cancer Council Victoria, and Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne; F.M. Cicuttini, MBBS, FRACP, PhD, Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Alfred Hospital
| | - Graham G Giles
- From the Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Alfred Hospital, Melbourne; Baker IDI Heart and Diabetes Institute; Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Carlton, Australia.Y. Wang, MBBS, MD, PhD, Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Alfred Hospital; S. Smith, MBBS, Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Alfred Hospital; A.J. Teichtahl, MBBS, B.Physio, FRACP, PhD, Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Alfred Hospital, and Baker IDI Heart and Diabetes Institute; A.M. Hodge, BAgrSci, Grad Dip Diet, BSc, MEnvSc, Grad Dip Epi Biostats, Cancer Epidemiology Centre, Cancer Council Victoria; A.E. Wluka, MBBS, FRACP, PhD, Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Alfred Hospital; G.G. Giles, PhD, Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Alfred Hospital, and Cancer Epidemiology Centre, Cancer Council Victoria, and Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne; F.M. Cicuttini, MBBS, FRACP, PhD, Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Alfred Hospital
| | - Flavia M Cicuttini
- From the Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Alfred Hospital, Melbourne; Baker IDI Heart and Diabetes Institute; Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Carlton, Australia.Y. Wang, MBBS, MD, PhD, Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Alfred Hospital; S. Smith, MBBS, Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Alfred Hospital; A.J. Teichtahl, MBBS, B.Physio, FRACP, PhD, Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Alfred Hospital, and Baker IDI Heart and Diabetes Institute; A.M. Hodge, BAgrSci, Grad Dip Diet, BSc, MEnvSc, Grad Dip Epi Biostats, Cancer Epidemiology Centre, Cancer Council Victoria; A.E. Wluka, MBBS, FRACP, PhD, Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Alfred Hospital; G.G. Giles, PhD, Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Alfred Hospital, and Cancer Epidemiology Centre, Cancer Council Victoria, and Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne; F.M. Cicuttini, MBBS, FRACP, PhD, Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Alfred Hospital
| |
Collapse
|
7
|
Ahedi HG, Aitken DA, Blizzard LC, Ding CHH, Cicuttini FM, Jones G. Correlates of Hip Cartilage Defects: A Cross-sectional Study in Older Adults. J Rheumatol 2016; 43:1406-12. [PMID: 27252427 DOI: 10.3899/jrheum.151001] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 04/12/2016] [Indexed: 11/22/2022]
Abstract
OBJECTIVE Knee cartilage defects are a key feature of osteoarthritis (OA) but correlates of hip defects remain unexplored. The aims of this cross-sectional study were to describe the correlates of hip cartilage defects. METHODS The study included 194 subjects from the Tasmanian Older Adult Cohort who had right hip short-tau inversion recovery magnetic resonance imaging (MRI). Hip cartilage defects were assessed and categorized as grade 0 = no defects, grade 1 = focal blistering or irregularities on cartilage or partial thickness defect, and grade 2 = full thickness defect. Hip pain was determined by Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC). Hip structural changes were measured on MRI, and hip radiographic OA (ROA) was assessed. Leg strength and physical activity were assessed using dynamometer and pedometers, respectively. Data were analyzed using log binomial and linear regression. RESULTS Of 194 subjects, 24% (n = 48) had no defects, 34% (n = 66) had grade 1, and 41% (n = 80) had grade 2. In multivariable analyses, any hip defects were associated with greater hip pain [prevalence ratio (PR) 1.20, 95% CI 1.02-1.35] and lower mean leg strength (men; mean ratio 0.83, 95% CI 0.67-0.98). Grade 1 defects were associated with hip bone marrow lesions (BML; PR 1.42, 95% CI 1.03-1.96) and high cartilage signal (men; PR 1.84, 95% CI 1.27-2.70), but not with hip pain or other structural findings. Grade 2 defects were associated with greater hip pain (PR 1.40, 95% CI 1.09-1.80), hip BML (PR 1.45, 95% CI 1.15-1.85), hip effusion cross-sectional area (PR 1.14, 95% CI 1.01-1.30), hip ROA (men; PR 1.60, 95% CI 1.13-2.25), and steps/day (PR 0.97, 95% CI 0.96-0.99). CONCLUSION Grade 2 defects in both sexes and grade 1 defects (mostly in men) are associated with clinical, demographic, and structural factors relevant for OA. Damage to the hip cartilage could be one of the major causes of rapid disease progression and pathophysiology of hip defects. The topic needs further study.
Collapse
Affiliation(s)
- Harbeer G Ahedi
- From the Menzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania; Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Alfred Hospital, Melbourne, Australia.H.G. Ahedi, BAMS, PgdipBioMedSc, Menzies Institute for Medical Research, University of Tasmania; D.A. Aitken, PhD, Menzies Institute for Medical Research, University of Tasmania; L.C. Blizzard, PhD, Menzies Institute for Medical Research, University Of Tasmania; C.H. Ding, MD, Menzies Institute for Medical Research, University of Tasmania, and Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Alfred Hospital; F.M. Cicuttini, PhD, FRACP, FAFPHM, Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Alfred Hospital; G. Jones, MD, Menzies Institute for Medical Research, University of Tasmania
| | - Dawn A Aitken
- From the Menzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania; Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Alfred Hospital, Melbourne, Australia.H.G. Ahedi, BAMS, PgdipBioMedSc, Menzies Institute for Medical Research, University of Tasmania; D.A. Aitken, PhD, Menzies Institute for Medical Research, University of Tasmania; L.C. Blizzard, PhD, Menzies Institute for Medical Research, University Of Tasmania; C.H. Ding, MD, Menzies Institute for Medical Research, University of Tasmania, and Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Alfred Hospital; F.M. Cicuttini, PhD, FRACP, FAFPHM, Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Alfred Hospital; G. Jones, MD, Menzies Institute for Medical Research, University of Tasmania
| | - Leigh C Blizzard
- From the Menzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania; Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Alfred Hospital, Melbourne, Australia.H.G. Ahedi, BAMS, PgdipBioMedSc, Menzies Institute for Medical Research, University of Tasmania; D.A. Aitken, PhD, Menzies Institute for Medical Research, University of Tasmania; L.C. Blizzard, PhD, Menzies Institute for Medical Research, University Of Tasmania; C.H. Ding, MD, Menzies Institute for Medical Research, University of Tasmania, and Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Alfred Hospital; F.M. Cicuttini, PhD, FRACP, FAFPHM, Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Alfred Hospital; G. Jones, MD, Menzies Institute for Medical Research, University of Tasmania
| | - Chang-Hai H Ding
- From the Menzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania; Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Alfred Hospital, Melbourne, Australia.H.G. Ahedi, BAMS, PgdipBioMedSc, Menzies Institute for Medical Research, University of Tasmania; D.A. Aitken, PhD, Menzies Institute for Medical Research, University of Tasmania; L.C. Blizzard, PhD, Menzies Institute for Medical Research, University Of Tasmania; C.H. Ding, MD, Menzies Institute for Medical Research, University of Tasmania, and Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Alfred Hospital; F.M. Cicuttini, PhD, FRACP, FAFPHM, Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Alfred Hospital; G. Jones, MD, Menzies Institute for Medical Research, University of Tasmania
| | - Flavia M Cicuttini
- From the Menzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania; Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Alfred Hospital, Melbourne, Australia.H.G. Ahedi, BAMS, PgdipBioMedSc, Menzies Institute for Medical Research, University of Tasmania; D.A. Aitken, PhD, Menzies Institute for Medical Research, University of Tasmania; L.C. Blizzard, PhD, Menzies Institute for Medical Research, University Of Tasmania; C.H. Ding, MD, Menzies Institute for Medical Research, University of Tasmania, and Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Alfred Hospital; F.M. Cicuttini, PhD, FRACP, FAFPHM, Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Alfred Hospital; G. Jones, MD, Menzies Institute for Medical Research, University of Tasmania
| | - Graeme Jones
- From the Menzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania; Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Alfred Hospital, Melbourne, Australia.H.G. Ahedi, BAMS, PgdipBioMedSc, Menzies Institute for Medical Research, University of Tasmania; D.A. Aitken, PhD, Menzies Institute for Medical Research, University of Tasmania; L.C. Blizzard, PhD, Menzies Institute for Medical Research, University Of Tasmania; C.H. Ding, MD, Menzies Institute for Medical Research, University of Tasmania, and Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Alfred Hospital; F.M. Cicuttini, PhD, FRACP, FAFPHM, Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Alfred Hospital; G. Jones, MD, Menzies Institute for Medical Research, University of Tasmania.
| |
Collapse
|